Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-07

FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ABSORICA (isotretinoin) filed by Sun Pharmaceutical Industries, expanding/updating the drug’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABSORICA (isotretinoin)

Snippet

SUPPL AP for ABSORICA (ISOTRETINOIN)